Lina Pan
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
TNMD BRICHOS domain attenuates tau pathology and memory deficits in a mouse model of tauopathy.
Journal: Cell death & disease
Published: August 27, 2025
Galectin-9 activates microglial asparagine endopeptidase and promotes α-synuclein pathology in Parkinson's disease.
Journal: Cell death and differentiation
Published: December 28, 2024
Microglia-derived Galectin-9 drives amyloid-β pathology in Alzheimer's disease.
Journal: Aging cell
Published: May 16, 2024
The yeast prion protein Sup35 initiates α-synuclein pathology in mouse models of Parkinson's disease.
Journal: Science advances
Published: November 01, 2023
GDF1 ameliorates cognitive impairment induced by hearing loss.
Journal: Nature aging
Published: June 21, 2023
The PM20D1-NADA pathway protects against Parkinson's disease.
Journal: Cell death and differentiation
Published: May 25, 2023
Islet amyloid polypeptide triggers α-synuclein pathology in Parkinson's disease.
Journal: Progress in neurobiology
Published: December 06, 2022
Fine Particulate Matter Triggers α-Synuclein Fibrillization and Parkinson-like Neurodegeneration.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: March 01, 2022
7,8-Dihydroxyflavone ameliorates mitochondrial impairment and motor dysfunction in the α-synuclein 1-103 transgenic mice.
Journal: Neurobiology of disease
Published: December 25, 2021
Tau accelerates α-synuclein aggregation and spreading in Parkinson's disease.
Journal: Brain : a journal of neurology
Published: November 29, 2021
Transgenic Mice Expressing Human α-Synuclein 1-103 Fragment as a Novel Model of Parkinson's Disease.
Transgenic Mice Expressing Human α-Synuclein 1-103 Fragment as a Novel Model of Parkinson's Disease.
Journal: Frontiers in aging neuroscience
Published: August 18, 2021
Last Updated: 09/26/2026